Company: VITALCARE DIABETES T (VDTI.PK)
Yahoo Finance: http://finance.yahoo.com/q?s=VDTI.PK
Company Websites: http://www.vitalcaretechnology.com

I’m excited to tell you, since deciding to make VDTI my stock
pick…

The company has announced FDA approval of the device used in
the therapy I told you about!

For those who’ve been a member for a few months, you’ll know
that FDA approval in the medical industry is one of the biggest
developments a company like this can make.

This development has only served to strengthen what I told
you last night, and has given me even more reason to believe
VDTI.PK could soar in price.

First though let me tell you a little about Diabetes, the
problem VDTI.PK aim to solve.

Diabetes affects 20.8 million people, in the United States.
That’s 7% of the entire population, and treatment of this 7%
cost the US economy $174 billion in 2007.

And yet the problem is only set to get worse, the cost of
treating diabetes (to the US Government) has already risen
by 32% since 2002.

And since Diabetes is caused by obesity (and thus unhealthy
fast-food driven lifestyles) experts agree that the problem
is set to get worse.

(The current estimate is that those affected will rise by 42%
in just a couple of years).

Diabetes already accounts for 18% of total hospital costs, as
hospital costs are 6 times higher for a person with diabetes
than for one without diabetes.

Now, I think we can both agree Diabetes is a major problem.
It is a condition which is given far less media coverage
than Cancer yet it affects 7% of the population and inhibits
their daily life indefinitley (there is no “real” cure).

… But VDTI’s (now FDA approved) solution could ensure
sufferers live a life where their body functions as normal.

The therapy would allow for Diabetics to function just like
normal.

Let me explain…

Insulin keeps Diabetes sufferers alive, but it’s not a cure.
All diabetics, no matter how healthy they may seem, will begin
developing a secondary medical complication as a result of
their diabetes.

Perhaps unlike any other disease, diabetes adversely affects
all aspects of the diabetic and his or her whole family.

All aspects of life are virtually controlled by diabetes.
Eating, sleeping, physical activities, sexual function, work,
travel, and the overall way that diabetic person feels, are
dependent on controlling the disease, and require constant
attention.

A diabetic person constantly works to maintain his or her
blood sugar level within a “tight range” as this is all that
they can try to do. There are no vacations from this disease,
even for a few hours.

And because there is no cure, and will be no cure for the
foreseeable future… The best “cure” available is to ensure
the body continues to function as close to normal as possible.

VDTI have done just that.

The company is the sole and exclusive licensor of iCAT therapy.
(by the way, iCAT stands for Intracellular Activation Therapy)…

The iCAT therapy uses a special “micro-pulse” insulin pump,
with extremely sophisticated proprietary software (algorithms)
incorporated into its logic.

The pump delivers small “micro doses” of insulin in a pattern
which mimics the way a normal pancreas secretes insulin which
is used by the liver.

iCAT Therapy also uses “real-time” measurements of the patient’s
blood sugar levels and bodywide metabolic rate by the use of
a “metabolic measurement cart”.

(Note: My understanding of “metabolic rate” is that it is in
fact just how fast your “whole system” runs. As it is the rate
you convert energy stores into working energy in your body).

And I have found that the whole problem with diabetes is that
it stops your body from making the energy required to live.

Anyhow…

This measurement data is inputted into the pump which
automatically adjusts the next insulin dosage to stimulate
a more normal metabolism.

… So it is much more advanced than anything at the moment.
Currently insulin is injected at a constant rate, this piece
of equipment actually measures and calculates exactly what
your body needs.

Shortly the body’s cells begin to utilize glucose, (the main
thing that people with diabetes cannot do normally). This
treatment therefore restores the normal functioning of the
body which promotes healing.

No other technology or protocol has ever demonstrated this
level of success.

And it was this device, which had me excited about the company
when I decided to make it this week’s pick. But just the other day…

VDTI Announced:

FDA Approval of iCAT Therapy!

The price has not changed, but overnight the company has in
my opinion became intrinsically more valuable… Based simply
on this development.

I cannot stress enough that FDA approval, in this industry is
a huge development for a company. Which is why FDA approval is
otherwise known as “allowance to market”.

Now I also said last night, that no matter how strong a company
looks… If they don’t have a viable, clear and realistic route
to market (and thus revenue coming in) I will not invest.

… And usually, bio-tech companies such as this do not have
a clear route to financial success. Most see curing whatever
disease as the main obstacle…

Although from an investors standpoint, no matter how big a medical
breakthough is possible, if there is not a clearly defined
way of generating revenue then it is not a business worth
investment.

I’ve already told you how big the diabetes market is, 7% of
the U.S. population suffer from the condition… It most likely
affects someone you know.

And in 2007 diabetes cost the U.S. $174 billion. Most of this
cost, was in terms of medical expenditure.

So what is VDTI’s route to market?

In my research, surprisingly (for a bio-tech company) VDTI.PK have
a clear route to market and thus revenue…

Just yesterday, in the same press release that announced FDA
approval, Jimmy McDougald the CEO said…

“With the only FDA approved device delivering this treatment,
we will expect to sign agreements to start the establishment
of iCAT Treatment Centers immediately.”

You’ see VDTI.PK have the product complete, it is FDA approved
and so obviously does what they claim (helps treat Diabetes).

VDTI.PK can immediately start using joint ventures to open their
own specialist iCAT treatment centers… And they can even
start licensing the treatment for use in already established
diabetes clinics almost immediately.

(There are thousands of independent diabetes clinics across
the U.S.)

Each of these clinics will be able to license the iCAT treatment
equipment… And because the equipment is relatively cheap
to produce (now all the scientific work is done), profit margins
are spectacular.

Now, everything I’ve mentioned points towards VDTI.PK being a strong
company with a strong and experienced management team.

But up until now, despite this, the company has remained
overlooked.

And even FDA approval would be a wasted development if there
were no investors watching the stock in the first place.

(By the way, it is because this company is overlooked that I
believe it is so cheap for what the company has already
accomplished).

Overnight… FDA Approval has made the current price an even
bigger bargain, in my opinion.

However in last nights email I also mentioned that recently
there has been a lot of media attention placed on Diabetes.

http://www.cbsnews.com/stories/2008/04/17/60minutes/main4023451.shtml?source=mostpop_story

http://news.bbc.co.uk/1/hi/health/7361276.stm

CBSNews even made it one of their top stories just the other
day.

And when the large media networks lavish attention on a certain
problem, in my experience, public companies whom address this
problem seem to make small but noticeable gains.

Now these gains are usually so small, they are not worth
pursuing as even the cost of trading will eat up the small
profit on offer.

But with a micro-cap company, I believe this attention could
see the stock price soar. Especially with a relatively new,
and overlooked firm such as VDTI.

And as this company is also now on the brink of success, with
the announcement of FDA approval… It is sure to catch the
attention of even more investors as the problem is raised by
the mass media.

Best Regards,
Michael Cohen

P.S. I researched VDTI.pk from their website, press releases, and
other public information on this company. It is always advisable
that you do your own research, and see for yourself what makes
this company special.

I’ve uploaded a document the company created, which forms a good
basis for your research…

(See: http://doublingstocks.com/vc_profile.pdf)

However…

Because I chose VDTI based on a great product and a clear route to
market but also because of mass media coverage of the very problem
VDTI aim to solve…

It is in my opinion extremely time sensitive and if you are reading
this email more than 24 hours after being sent, please don’t even
bother.

Popularity: 6% [?]